Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

NCT01545778 · clinicaltrials.gov ↗

COMPLETED

Status

646620

Enrollment

INDUSTRY

Sponsor class

Conditions

Substance Abuse Detection

Interventions

DRUG: Tapentadol IR
DRUG: Oxycodone IR

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.